Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Onconetix, Inc.
| Metric | Onconetix, Inc. ONCOHealthcare |
|---|---|
| Quality Score | 37 / 100 |
| Revenue (latest) | $815,371 |
| Net income (latest) | −$14M |
| Operating margin | −2190.0% |
| Net margin | −1721.0% |
| Return on equity | −89.0% |
| Return on assets | −56.3% |
| Return on capital (ROCE) | −113.1% |
| Debt / equity | 0.58× |
| Revenue growth (YoY) | −67.7% |
| Altman Z″ (distress) | -20.98 |
| Accruals / assets | −17.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.